Biopolymer Surfactants for Sealing Electroporated Membranes

用于密封电穿孔膜的生物聚合物表面活性剂

基本信息

  • 批准号:
    7320556
  • 负责人:
  • 金额:
    $ 35.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-04-01 至 2011-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Disruption of the plasma membrane's lipid bilayer structure with subsequent loss of its transport barrier function is the mechanism of tissue death in trauma, muscular dystrophies, reperfusion injuries and common diseases. Plasma membrane breakdown is followed by rapid metabolic energy exhaustion, then acute cellular necrosis. It is now well established that certain biocompatible multiblock copolymer surfactants, especially poloxamer 188, are effective in sealing of disrupted cell membranes and can prevent acute necrosis if delivered within a few hours after injury. (Appendix A). It is likely that P188 will soon be a standard component of trauma resuscitation fluids and will have a broad impact on medicine therapeutics. However, P188 may not be the ideal surfactant for membrane repair. It is rapidly degraded by oxygen free radicals into fragments that can be cytotoxic. Thus, it is necessary to determine the intermolecular interactions responsible for surfactant sealing of disrupted membranes so that more stable multiblock copolymer surfactants that seal membranes can be developed. We will test the prevailing hypothesis that sealing surfactants that seal bilayer lipid membranes do so by altering interfacial water structure, thus reducing membrane tension, which then permits reorganization of membrane lipids into a lipid bilayer. We will use established methods (Appendix C) to measure membrane tension while perturbing water structure around permeabilized membranes. The threshold membrane tensions for sealing will be determined for at least two different cell types. We plan to determine sealing efficacy as function of copolymer surfactant structure and determine suitable size of hydrophobic and hydrophilic moieties. We will also perform high resolution measurements of membranes structure and mechanical properties, before and after sealing (Appendix E). Finally, we will conduct studies in parallel to determine if surfactant rescued cells manifest normal phenotype during proliferation or exhibit effects of mutations caused by unrepaired DMA.
描述(由申请人提供):质膜脂质双层结构的破坏及其随后的转运屏障功能丧失是创伤、肌营养不良、再灌注损伤和常见疾病中组织死亡的机制。质膜破裂后,代谢能量迅速耗尽,然后是急性细胞坏死。现在已经确定,某些生物相容性多嵌段共聚物表面活性剂,特别是泊洛沙姆188,在密封破裂的细胞膜方面是有效的,并且如果在损伤后几小时内递送,可以防止急性坏死。(附录A)。P188很可能很快成为创伤复苏液的标准成分,并将对医学治疗产生广泛影响。然而,P188可能不是膜修复的理想表面活性剂。它被氧自由基迅速降解成具有细胞毒性的片段。因此,有必要确定分子间的相互作用,负责表面活性剂密封破裂的膜,使更稳定的多嵌段共聚物表面活性剂,密封膜可以开发。我们将测试流行的假设,密封表面活性剂密封双层脂质膜这样做,通过改变界面水结构,从而降低膜张力,然后允许重组成脂质双层的膜脂质。我们将使用已建立的方法(附录C)来测量膜张力,同时扰动透化膜周围的水结构。将针对至少两种不同的细胞类型确定用于密封的阈值膜张力。我们计划确定密封功效作为共聚物表面活性剂结构的函数,并确定疏水和亲水部分的合适尺寸。我们还将在密封前后对膜结构和机械性能进行高分辨率测量(附录E)。最后,我们将进行平行研究,以确定表面活性剂拯救的细胞在增殖过程中是否表现出正常的表型,或表现出未修复的DMA引起的突变的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAPHAEL Carl LEE其他文献

RAPHAEL Carl LEE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAPHAEL Carl LEE', 18)}}的其他基金

Trauma Molecular Pathogenesis and Regeneration Training Grant
创伤分子发病机制和再生培训补助金
  • 批准号:
    8870377
  • 财政年份:
    2012
  • 资助金额:
    $ 35.78万
  • 项目类别:
Trauma Molecular Pathogenesis and Regeneration Training Grant
创伤分子发病机制和再生培训补助金
  • 批准号:
    8497695
  • 财政年份:
    2012
  • 资助金额:
    $ 35.78万
  • 项目类别:
Trauma Molecular Pathogenesis and Regeneration Training Grant
创伤分子发病机制和再生培训补助金
  • 批准号:
    8214779
  • 财政年份:
    2012
  • 资助金额:
    $ 35.78万
  • 项目类别:
Membrane Sealing:Biopolymers for Tissue Electroporation
膜密封:用于组织电穿孔的生物聚合物
  • 批准号:
    6608413
  • 财政年份:
    2002
  • 资助金额:
    $ 35.78万
  • 项目类别:
Biopolymer Surfactants for Sealing Electroporated Membranes
用于密封电穿孔膜的生物聚合物表面活性剂
  • 批准号:
    7482465
  • 财政年份:
    2002
  • 资助金额:
    $ 35.78万
  • 项目类别:
Membrane Sealing:Biopolymers for Tissue Electroporation
膜密封:用于组织电穿孔的生物聚合物
  • 批准号:
    6620869
  • 财政年份:
    2002
  • 资助金额:
    $ 35.78万
  • 项目类别:
Membrane Sealing:Biopolymers for Tissue Electroporation
膜密封:用于组织电穿孔的生物聚合物
  • 批准号:
    6725384
  • 财政年份:
    2002
  • 资助金额:
    $ 35.78万
  • 项目类别:
Membrane Sealing:Biopolymers for Tissue Electroporation
膜密封:用于组织电穿孔的生物聚合物
  • 批准号:
    6422636
  • 财政年份:
    2002
  • 资助金额:
    $ 35.78万
  • 项目类别:
Biopolymer Surfactants for Sealing Electroporated Membranes
用于密封电穿孔膜的生物聚合物表面活性剂
  • 批准号:
    7625195
  • 财政年份:
    2002
  • 资助金额:
    $ 35.78万
  • 项目类别:
Membrane Sealing:Biopolymers for Tissue Electroporation
膜密封:用于组织电穿孔的生物聚合物
  • 批准号:
    6875021
  • 财政年份:
    2002
  • 资助金额:
    $ 35.78万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 35.78万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.78万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 35.78万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.78万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 35.78万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 35.78万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.78万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 35.78万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 35.78万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.78万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了